Pharmacyclics 10K 2010 Annual report | PCYC Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: abstract, Ac, adenocarcinoma, agreeme, ahead, aking, antitumor, appendiceal, arketing, arthritic, ASC, ASU, AUC, AYY, belinostat, Blazon, bore, broek, busin, cal, cate, CD, Celgene, ched, Chemother, Chesson, chnology, chose, chosen, clini, cohort, collapse, comm, complication, concomitant, Conroy, cont, CR, creation, crucial, curren, decli, degranulation, den, determ, di, disaggregation, dispensed, DLBCL, DLT, Du, ductal, eatment, ed, eeting, eleven, endothelial, entirety, Epigenetic, eq, er, ercial, ess, establi, Evan, evelopment, expansion, fibrin, figure, financia, FL, flat, footnote, fourteen, fu, Furt, gap, Gerard, ggan, Heidelberg, hen, hholding, hold, Honigberg, Honigbert, hout, hypersensitivity, Ia, Ib, ical, ich, ID, IL, ility, imit, Importantly, indi, input, intracellular, inue, invited, ired, irinotecan, irreversible, irreversibly, ITT, iv, ive, JCO, kg, Klerk, lab, Lee, Lett, liab, lie, lll, ma, manifested, mantle, manuscript, margin, Marginal, mat, MCL, Mechanim, microenvironment, mis, mission, monotherapy, nagerial, ne, nes, neutropenia, nonrecurring, nt, Obama, occupied, Oncol, ordinary, Orlando, ORR, ou, oxaliplatin, pamobinostat, paper, PatientBase, Permanent, Pharmacol, physical, PK, postdose, prevalent, print, proceed, prod, proinflammatory, proteolytic, quantitative, reclaimed, reconciliation, refractory, regressio, regu, reoccurred, repeated, requ, residual, rest, revised, revision, RR, SD, Servi, Session, settled, shed, sixteen, Spectrum, strengt, stribution, tangible, te, terri, tly, TPE, tr, tual, tunor, ture, UCLA, UCSF, uity, UK, umor, unde, upd, ur, USA, van, variability, VEGF, vendor, vessel, Vlla, Vol, VSOE, weekly, wh, wi, wit, withdrew, Workshop, xenograft, xt, Yang

Removed: Accountant, Acquiring, adjustment, ASP, awarded, bidding, Bioscience, cancelled, CAP, category, comprehensive, consumer, curative, cytotoxicity, description, detected, Emerging, estate, fewer, FIN, finally, growing, implemented, infused, inInternal, injectable, interpretation, invasion, joined, listed, Los, mature, maximize, media, misstatement, negatively, NIH, Nominating, nonstatutory, nuclear, occurring, offered, outpatient, participating, PDF, Pennsylvania, Pharmacology, privately, Professor, progressively, promoted, real, remeasure, repayment, repurchased, School, Secretary, sensitivity, skin, SMART, statistical, Supplementary, surgical, synthetic, Task, threshold, top, toxic, toxicology, venture, Winning, worked, York

Pharmacyclics (PCYC) Inactive 10-K2010 FY Annual report

Content analysis